Phil Troke
Publications by Year
Research Areas
Hepatitis C virus research, Hepatitis B Virus Studies, Systemic Lupus Erythematosus Research, Liver Disease Diagnosis and Treatment, HIV/AIDS drug development and treatment
Most-Cited Works
- → Interferon lambda 4 impacts the genetic diversity of hepatitis C virus(2019)146 cited
- → Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy(2021)35 cited
- → In Vitro Characterization of the Activity of PF-05095808, a Novel Biological Agent for Hepatitis C Virus Therapy(2011)14 cited
- → Real-world retreatment of HCV-infected patients with prior failure to direct acting antiviral therapy using sofosbuvir, velpatasvir and voxilaprevir(2020)3 cited
- → Author response: Interferon lambda 4 impacts the genetic diversity of hepatitis C virus(2019)1 cited
- → Real World SOF/VEL/VOX Retreatment Outcomes and Viral Resistance Analysis for HCV Patients with Prior Failure to DAAs(2020)
- → A183 SOFOSBUVIR-BASED ALL-ORAL REGIMENS FOR PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 3 INFECTION: INTEGRATED ANALYSIS OF FIVE CLINICAL STUDIES(2018)
- → Micro-eliminating hepatitis C in a network of 47 English Prisons through an industry, prison healthcare and patient organisation partnership(2022)
- → HepCARE: A tool enabling the identification, assessment and management of viral hepatitis. An integrated approach to the patient journey(2018)
- Ledipasvir/Sofosbuvir plus Ribavirin (LDV/SOF+RBV) for 12 Weeks in Decompensated HCV Genotype 1 Patients: SOLAR-1 and-2 Studies Compared to a Real-World Dataset(2017)